341 related articles for article (PubMed ID: 37488645)
1. Overlap syndrome of autoimmune hepatitis and primary biliary cholangitis complicated with atypical hepatocellular carcinoma: a case report.
Surdea-Blaga T; Cărăguț RL; Caraiani C; Spârchez Z; Al Hajjar N; Dumitrașcu DL
J Med Case Rep; 2023 Jul; 17(1):328. PubMed ID: 37488645
[TBL] [Abstract][Full Text] [Related]
2. Risk factors for cancer in patients with primary biliary cholangitis and autoimmune hepatitis and primary biliary cholangitis overlap syndrome.
Braga MH; Cançado GGL; Bittencourt PL; Couto CA; Guedes LV; Lima AMC; Ferraz MLG; Villela-Nogueira CA; Nardelli MJ; Faria LC; Gomes NMF; Oliveira EMG; Rotman V; Oliveira MB; da Cunha SMCF; Cunha-Silva M; Mendes LSC; Ivantes CAP; Codes L; de Almeida E Borges VF; Pace FHL; Pessoa MG; Signorelli IV; Coral GP; Filho JG; Chagas AL; Terrabuio DRB; Cançado ELR;
Ann Hepatol; 2023; 28(4):101105. PubMed ID: 37088418
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies in Chinese patients with chronic hepatitis B: prevalence and clinical associations.
Li BA; Liu J; Hou J; Tang J; Zhang J; Xu J; Song YJ; Liu AX; Zhao J; Guo JX; Chen L; Wang H; Yang LH; Lu J; Mao YL
World J Gastroenterol; 2015 Jan; 21(1):283-91. PubMed ID: 25574103
[TBL] [Abstract][Full Text] [Related]
4. [Autoimmune hepatitis and overlap syndrome: diagnosis].
Berg PA; Klein R
Praxis (Bern 1994); 2002 Aug; 91(34):1339-46. PubMed ID: 12233264
[TBL] [Abstract][Full Text] [Related]
5. Overlap syndrome between autoimmune hepatitis and primary biliary cirrhosis complicated by hepatocellular carcinoma.
Gheorghe L; Iacob S; Bolog N; Stoicescu A; Pârvulescu I; Popescu I
Rom J Gastroenterol; 2004 Mar; 13(1):33-8. PubMed ID: 15054524
[TBL] [Abstract][Full Text] [Related]
6. [Clinical features of 107 autoimmune hepatitis patients and 30 of them with AIH-primary biliary cirrhosis overlap syndrome].
Qiu DK; Li XM; Wei J; Ye LJ; Peng YS; Ma X
Zhonghua Gan Zang Bing Za Zhi; 2008 May; 16(5):367-71. PubMed ID: 18510851
[TBL] [Abstract][Full Text] [Related]
7. [Differential characteristics of AMA-M2 autoantibody in primary biliary cirrhosis and non-PBC patients].
Sun L; Wang Y; Liu Y; Zhao Y; Zhang X; Wang Y; Zhao D; Zhang H; Ma Y
Zhonghua Gan Zang Bing Za Zhi; 2015 May; 23(5):343-9. PubMed ID: 26192239
[TBL] [Abstract][Full Text] [Related]
8. Hepatocellular carcinoma in primary sclerosing cholangitis and primary biliary cholangitis: a clinical and pathological study in an uncommon but emerging setting.
Bosch DE; Zen Y; Boukhar SA; Liu Y; Cheng L; Yeh MM
Virchows Arch; 2021 Dec; 479(6):1131-1143. PubMed ID: 34414507
[TBL] [Abstract][Full Text] [Related]
9. Retrospective analysis of autoimmune hepatitis-primary biliary cirrhosis overlap syndrome in Korea: characteristics, treatments, and outcomes.
Park Y; Cho Y; Cho EJ; Kim YJ
Clin Mol Hepatol; 2015 Jun; 21(2):150-7. PubMed ID: 26157752
[TBL] [Abstract][Full Text] [Related]
10. Autoimmune hepatitis - primary biliary cholangitis overlap syndrome. Long-term outcomes of a retrospective cohort in a university hospital.
Martínez Casas OY; Díaz Ramírez GS; Marín Zuluaga JI; Santos Ó; Muñoz Maya O; Donado Gómez JH; Restrepo Gutiérrez JC
Gastroenterol Hepatol; 2018 Nov; 41(9):544-552. PubMed ID: 30017212
[TBL] [Abstract][Full Text] [Related]
11. The diagnostic value of contrast-enhanced ultrasound LI-RADS for hepatocellular carcinoma in patients with cirrhosis and chronic hepatitis B.
Yang D; Hu H; Li R; Tang CL; Ma KS; Guo DY
Abdom Radiol (NY); 2022 Feb; 47(2):630-639. PubMed ID: 34910237
[TBL] [Abstract][Full Text] [Related]
12. Rates of decompensation, hepatocellular carcinoma and mortality in AMA-negative primary biliary cholangitis cirrhosis.
John BV; Dahman B; Deng Y; Khakoo NS; Taddei TH; Kaplan DE; Levy C
Liver Int; 2022 Feb; 42(2):384-393. PubMed ID: 34614294
[TBL] [Abstract][Full Text] [Related]
13. Hepatocellular carcinoma in patients with autoimmune hepatitis.
Teufel A; Weinmann A; Centner C; Piendl A; Lohse AW; Galle PR; Kanzler S
World J Gastroenterol; 2009 Feb; 15(5):578-82. PubMed ID: 19195059
[TBL] [Abstract][Full Text] [Related]
14. Therapy response and outcome of overlap syndromes: autoimmune hepatitis and primary biliary cirrhosis compared to autoimmune hepatitis and autoimmune cholangitis.
Ozaslan E; Efe C; Akbulut S; Purnak T; Savas B; Erden E; Altiparmak E
Hepatogastroenterology; 2010; 57(99-100):441-6. PubMed ID: 20698205
[TBL] [Abstract][Full Text] [Related]
15. PBC-AIH overlap syndrome with concomitant ITP and Hashimoto's disease with positivity for anti-centromere antibody.
Arakawa Y; Amaki S; Miyakawa H; Sakai T; Gotou I; Tanaka N; Moriyama M; Iwasaki A; Sugitani M; Arakawa Y
J Gastroenterol; 2004; 39(5):490-5. PubMed ID: 15175950
[TBL] [Abstract][Full Text] [Related]
16. Features of hepatocellular carcinoma in cases with autoimmune hepatitis and primary biliary cirrhosis.
Watanabe T; Soga K; Hirono H; Hasegawa K; Shibasaki K; Kawai H; Aoyagi Y
World J Gastroenterol; 2009 Jan; 15(2):231-9. PubMed ID: 19132775
[TBL] [Abstract][Full Text] [Related]
17. Incidence and predictors of hepatocellular carcinoma in patients with autoimmune hepatitis.
Colapietro F; Maisonneuve P; Lytvyak E; Beuers U; Verdonk RC; van der Meer AJ; van Hoek B; Kuiken SD; Brouwer JT; Muratori P; Aghemo A; Carella F; van den Berg AP; Zachou K; Dalekos GN; Di Zeo-Sánchez DE; Robles M; Andrade RJ; Montano-Loza AJ; van den Brand FF; Slooter CD; Macedo G; Liberal R; de Boer YS; Lleo A; ;
J Hepatol; 2024 Jan; 80(1):53-61. PubMed ID: 37802188
[TBL] [Abstract][Full Text] [Related]
18. Ulcerative colitis complicated by primary sclerosing cholangitis and autoimmune hepatitis overlap syndrome: a case report and literature review.
Zhang X; Lin X; Li X; Guan L; Li Y; Wang N
Front Immunol; 2023; 14():1132072. PubMed ID: 37228618
[TBL] [Abstract][Full Text] [Related]
19. Hepatocellular carcinoma in a patient with primary biliary cirrhosis and seronegativity for markers of hepatitis B virus and hepatitis C virus: report of a case.
Sunagawa H; Takayama H; Yamashiro T; Sasaki H; Sashida Y; Matsuura K; Kayou M
Surg Today; 2003; 33(3):219-23. PubMed ID: 12658391
[TBL] [Abstract][Full Text] [Related]
20. Investigation and analysis of HEp 2 indirect immunofluorescence titers and patterns in various liver diseases.
Wei Q; Jiang Y; Xie J; Yang M; Zhang Y; Wu Z; Chen S; Liao Z; Lin Z; Gu J
Clin Rheumatol; 2020 Aug; 39(8):2425-2432. PubMed ID: 32103375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
